Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 02, 2024 10:08 ET | Source: Transparency Market Research

Oligonucleotides Market Outlook 2034: Projected to Reach US$ 13.1 Billion by 2034, Driven by Expanding Applications in Biotechnology and Precision Medicine | TMR

Wilmington, Delaware, Transparency Market Research Inc.:, Dec. 02, 2024 (GLOBE NEWSWIRE) -- The global oligonucleotides market (mercado de oligonucleótidos) is poised for significant growth,...
October 02, 2023 13:17 ET | Source: Praxis Precision Medicines, Inc.

Praxis Precision Medicines Provides Portfolio Update at 2023 R&D Day

Positive results from preliminary analysis of PRAX-222 Part 1 showed 44% median reduction in seizures after three doses for SCN2A-gain-of-function pediatric patients Phase 3 (Essential3) program for...
April 12, 2023 08:30 ET | Source: Future Market Insights Global and Consulting Pvt. Ltd.

Global Vutrisiran Market is set to surpass a revenue of US$ 2 Billion by 2033, expanding at a 12% CAGR during the forecast period | Data by Future Market Insights, Inc.

NEWARK, Del, April 12, 2023 (GLOBE NEWSWIRE) -- During the forecast period 2023 to 2033, the Vutrisiran Market is expected to grow at a value of 12% CAGR, according to Future Market Insights. By the...
November 29, 2021 08:00 ET | Source: Praxis Precision Medicines, Inc.

Praxis Precision Medicines to Present Data from Rare Disease Programs at the American Epilepsy Society 2021 Annual Meeting

BOSTON, Nov. 29, 2021 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies...